Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Albany Molecular Research, Inc. (AMRI) To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Albany Molecular Research, Inc. (“Albany” or the “Company”) (NASDAQ: AMRI) of the January 12, 2015 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Albany and certain officers of the Company.
A complaint has been filed in the United States District Court for the Eastern District of New York on behalf of all persons who purchased Albany common stock between August 5, 2014 and November 5, 2014 (the “Class Period”).
The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.
Specifically, the action alleges that during the Class Period, Albany issued false and misleading statements concerning operations at its OsoBio facility.
On November 5, 2014, the Company announced that a business interruption event at its OsoBio facility in late July resulted in weak third quarter 2014 results and that the facility would not be back online until mid-November.
Following this news, the price of Albany’s stock declined by $6.08 per share, or over 26%, to close on November 5, 2014 at $16.59 per share.
If you invested in Albany common stock, bonds or options between August 5, 2014 and November 5, 2014 you can contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Albany’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.